Very rapid virologic response and early HCV response kinetics, as quick measures to compare efficacy and guide a personalized response-guided therapy

BACKGROUND: This is the second and final report for our study designed to compare two generic sofosbuvir products for the degree and speed of virologic response to a dual anti-hepatitis C virus (HCV) treatment protocol. We aimed to test the applicability of the early virus response kinetics and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakoot, Mostafa, Abdo, Alaa M, Yousry, Ahmed, Helmy, Sherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003574/
https://www.ncbi.nlm.nih.gov/pubmed/27601883
http://dx.doi.org/10.2147/DDDT.S111496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003574/
https://www.ncbi.nlm.nih.gov/pubmed/27601883
http://dx.doi.org/10.2147/DDDT.S111496

Ejemplares similares